Brian Ball
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brian Ball as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:22 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06575296 · Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell TransplantCity of Hope Medical Center · recruiting · Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia · principal investigator
- Ph1NCT05441514 · Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaCity of Hope Medical Center · completed · Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026Named on NCT06575296, NCT05441514
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:22 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- 151 citationsRCR 5.5
- Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone.J Allergy Clin Immunol · 199972 citationsRCR 2.2
- Allergen bronchoprovocation of patients with mild allergic asthma after ozone exposure.J Allergy Clin Immunol · 199641 citationsRCR 1.7
- Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.Ann Allergy · 199040 citationsRCR 1.4
- Uncovering continuous and transient monitoring profiles in event-based prospective memory.Psychon Bull Rev · 201524 citationsRCR 1.3
- Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.Blood Adv · 201824 citationsRCR 0.8
- Endocrine changes, fetal growth, and uterine artery hemodynamics after chronic estrogen suppression during the last trimester of equine pregnancy.Biol Reprod · 201722 citationsRCR 1.4
- Simulated versus traditional therapeutic radiography placements: A randomised controlled trial.Radiography (Lond) · 202019 citationsRCR 2.7
- Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.Blood Adv · 202319 citationsRCR 1.6
- Examining depletion theories under conditions of within-task transfer.J Exp Psychol Gen · 201714 citationsRCR 0.9